Imidazo-pyrazine derivatives as potent CXCR3 antagonists

Xiaohui Du; Darin J. Gustin; Xiaoqi Chen; Jason Duquette; Lawrence R. McGee; Zhong Lin Wang; Karen Ebsworth; Kirk R. Henne; Bryan D. Lemon; Ji Ma; Shichang Miao; Emmanuel Sabalan; Timothy J. Sullivan; George Tonn; Tassie L. Collins; Julio C. Medina

doi:10.1016/j.bmcl.2009.07.021

Article2011

Synthesis of Imidazo[1,2-a]pyridine Derivatives as Antiviral Agents

Sylvie Mavel, Jean Louis Renou, Christophe Galtier, Robert Snoeck, Graciela Andreï, Jan Balzarini, De Clercq Erik, Alain Gueiffier

Article2001

ChemInform Abstract: Synthesis of Imidazo[1,2‐a]pyridine Derivatives as Antiviral Agents.

Sylvie Mavel, Jean Louis Renou, Christophe Galtier, Robert Snoeck, Graciela Andreï, Jan Balzarini, De Clercq Erik, Alain Gueiffier

Article2016

SYNTHESIS OF IMIDAZO[2,1-b][1,3,4]THIADIAZOLE DERIVATIVES AS POSSIBLE BIOLOGICALLY ACTIVE AGENTS.

Sujeet Kumar, Basavaraj Metikurki, Vivek Bhadauria, De Clercq Erik, Dominique Schols, Harukuni Tokuda, Subhas S. Karki

Article2013

Synthesis of novel indenoquinoxaline derivatives as potent α-glucosidase inhibitors

Madiha Sahar Khan, Munawar Ali Munawar, Mohammad Ashraf, Umber Alam, Athar Ata, Abdullah Mohamed Asiri, Samina Kousar, Misbahul Ain Khan

Article2009

Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors

Dustin L. McMinn, Yosup Rew, Athena Sudom, Seb Caille, Michael DeGraffenreid, Xiaodong He, Randall W. Hungate, Ben Jiang, Juan C. Jaén, Lisa D. Julian, Jacob A. Kaizerman, Perry M. Novak, Daqing Sun, Hua Tu, Stefania Ursu, Nigel P.C. Walker, Xuelei Yan, Qiuping Ye, Zhong Lin Wang, Jay P. Powers

Imidazo-pyrazine derivatives as potent CXCR3 antagonists

Discussion(0)

Related publications

Synthesis of Imidazo[1,2-a]pyridine Derivatives as Antiviral Agents

ChemInform Abstract: Synthesis of Imidazo[1,2‐a]pyridine Derivatives as Antiviral Agents.

SYNTHESIS OF IMIDAZO[2,1-b][1,3,4]THIADIAZOLE DERIVATIVES AS POSSIBLE BIOLOGICALLY ACTIVE AGENTS.

Synthesis of novel indenoquinoxaline derivatives as potent α-glucosidase inhibitors

Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors